InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-28.2%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Stuart Bryan, Autre. Director active across 1 company, notably Fulcrum Therapeutics, Inc.. In total, 2 filings have been logged. Activity tracked since 10 August 2021. The latest transaction was filed on 10 August 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
32,000 shares@ US$7.840.048% mcap50.0% of flowCommon StockSEC:0000899243-21-032753:0
32,000 shares@ US$7.8450.0% of flowCommon StockSEC:0000899243-21-032753
2 of 2 declarations
About Stuart Bryan
Bryan Stuart is a key member of Fulcrum Therapeutics, Inc. Although his exact role is not specified, he contributes to the company's mission in the field of innovative therapies. His expertise and commitment are essential for the development of therapeutic solutions.
